Shanghai Wennai Pharmaceutical Technology Co. Ltd. has disclosed sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers reported to be useful for the treatment of acute and chronic pain.
Some of the main targets of these injured nerves are the voltage gated sodium channels NaV1.7 and NaV1.8. The McDougall Lab has found that opening of NaV1.8 channels causes joint pain. We have shown ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback